Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,580,262 papers from all fields of science
Search
Sign In
Create Free Account
KIAA1524 gene
Known as:
KIAA1524
, CIP2A
, p90
Expand
This gene is involved in phosphatase inhibition and anchorage-independent cell growth.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (1)
Genes
Narrower (1)
KIAA1524 wt Allele
Protein CIP2A
Stimulation of Cell Proliferation
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
CIP2A Promotes Proliferation, Invasion and Chemoresistance to Cisplatin in Renal Cell Carcinoma
Yong-zhen Zhang
,
Liang Fang
,
Yuanwei Zang
,
Juchao Ren
,
Zhonghua Xu
Journal of Cancer
2018
Corpus ID: 53211393
CIP2A is a well-known oncoprotein whose expression is elevated in multiple human solid tumor types. However, its role in renal…
Expand
2018
2018
DAPK and CIP2A are involved in GAS6/AXL-mediated Schwann cell proliferation in a rat model of bilateral cavernous nerve injury
Yen-Lin Chen
,
Y. Tsai
,
+6 authors
H. Chiang
OncoTarget
2018
Corpus ID: 3470682
Purpose Impotence is one of the major complications occurring in prostate cancer patients after radical prostectomy (RP). Self…
Expand
2017
2017
Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in JAK2V617F mutated cells through PP2A/CIP2A axis
N. Bartalucci
,
L. Calabresi
,
+6 authors
A. Vannucchi
OncoTarget
2017
Corpus ID: 54484753
Inhibition of the constitutively activated JAK/STAT pathway in JAK2V617F mutated cells by the JAK1/JAK2 inhibitor ruxolitinib…
Expand
2017
2017
Increase in CIP2A expression is associated with cisplatin chemoresistance in gastric cancer.
Juanli Ji
,
Weiguo Zhen
,
+9 authors
Y. Liu
Cancer Biomarkers
2017
Corpus ID: 3241886
BACKGROUND The cancerous inhibitor of protein phosphatase 2A (CIP2A) is an oncoprotein which involves in the progression of…
Expand
2015
2015
SNP rs34172460 (S258A)Â in Gene CIP2A Correlates with Bortezomib Resistance in Multiple Myeloma Patients
George Y Tang
,
Mingjie Li
,
+10 authors
J. Berenson
2015
Corpus ID: 78591817
Introduction: The proteasome inhibitor (PI) bortezomib is a novel anticancer drug that shows activity especially for treating…
Expand
2015
2015
Abstract 3557: Cancerous inhibitor of PP2A is a novel molecular target and resistance factor of Lapatinib
Ming Zhao
,
Amanda J. Blackwelder
,
Harry Lee
,
Xiaohe Yang
2015
Corpus ID: 74275652
Deregulation of erbB-2 and EGFR is frequently detected in breast cancer, which has been associated with poor prognosis. Lapatinib…
Expand
2014
2014
Expression patterns of microRNA-218 and its potential functions by targeting CIP2A and BMI1 genes in melanoma
Yanping Wei
,
Yuwen Du
,
+6 authors
Guoqiang Zhao
Tumor Biology
2014
Corpus ID: 17000202
Melanoma is the most aggressive skin cancer, and it is typically resistant or rapidly develops resistance to a variety of…
Expand
2011
2011
KIAA1524: A novel MLL translocation partner in acute myeloid leukemia.
E. Coenen
,
C. Zwaan
,
+5 authors
M. V. D. van den Heuvel-Eibrink
Leukemia research : a Forum for Studies on…
2011
Corpus ID: 20684591
2011
2011
ETS 1 Mediates MEK 1 / 2-Dependent Overexpression of Cancerous Inhibitor of Protein Phosphatase 2 A ( CIP 2 A ) in Human Cancer Cells
A. Khanna
,
Juha Okkeri
,
+4 authors
J. Westermarck
2011
Corpus ID: 54837274
EGFR-MEK-ERK signaling pathway has an established role in promoting malignant growth and disease progression in human cancers…
Expand
2009
2009
Tissue characterization using multiscale products of wavelet transform of ultrasound radio frequency echoes
M. Aboofazeli
,
P. Abolmaesumi
,
G. Fichtinger
,
P. Mousavi
Annual International Conference of the IEEE…
2009
Corpus ID: 10013556
This paper presents a novel method for tissue characterization using wavelet transform of ultrasound radio frequency (RF) echo…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE